Michelle Barron, MD
Professor, Medicine-Infectious Disease
Medical School
- MD, University of Texas Southwestern Medical Center at Dallas Southwestern Medical School (1996)
Undergraduate School
- BS, Yale University (CT) (1992)
Internship
- Creighton University Program (1997)
Residency
- Creighton University Program, Internal Medicine (1999)
Fellowships
- University of Colorado, Infectious Disease (2002)
Languages
English, SpanishDepartment
Medicine-Infectious DiseasePublications
- “Human Dendritic Cell Interactions with Whole Recombinant Yeast: Implications for HIV-1 Vaccine Development.” Journal of Clinical Immunology.
- Common Viral Infections in Transplant Recipients – Part 1: Herpes Viruses.” Clinical Microbiology Newsletter. 27(13): 99-106, and 27(14): 110-113. 2005 July.
- “Common Viral Infections in Transplant Recipients – Part 2: Respiratory viruses, Polyomaviruses, and Erythroviruses.” Clinical Microbiology Newsletter. 27(15):115-122.
- “Septic Platelet Transfusion Reactions due to Staphylococcus aureus.” Abstract/poster presentation at The Society for Healthcare Epidemiology of America (SHEA) 16th Annual Scientific Meeting, Chicago.
- 1. Hilts, A, Fish, D, Richardson, K, and Barron, M. “The Evaluation of a Flouroquinolone Restriction Policy at a University Teaching Hospital.” Abstract/poster presentation at the 17th European Congress of Clinical Microbiology and Infectious Diseases together with the 25th International Congress of Chemotherapy, Munich. 2007.
- 2. Fishman, N, Baillie, GM, Barron, MA, Brake, H. “Multicenter Evaluation of Fungal Prophylaxis in Solid Organ Transplantation.” Abstract/poster presentation at the 44th Ann. Mtg. of the Infectious Diseases Society of America (IDSA), Toronto. 2006.
- 3. Ostrosky-Zeichner, L, Pappas, P, Shoham, S, Reboli. A, Barron, M, Sims, C, Wood, C, Langendorfer, A, Sobel, J. “Revalidation and improvement of a clinical prediction rule (CPR) for clinical trials on prophylaxis of invasive candidiasis (IC) in the ICU.” Abstract/poster presentation at the 46th Ann. Mtg. of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco. 2006.
- 4. Barron, MA, Woods, P, Campbell, G, and Madinger, NE. “Septic Platelet Transfusion Reactions due to Staphylococcus aureus.” Abstract/poster presentation at The Society for Healthcare Epidemiology of America (SHEA) 16th Annual Scientific Meeting, Chicago. 2006.
- 1. Barron, MA, Blyveis, N, and Wilson, CC. “Human Dendritic Cell Interactions with Whole Recombinant Yeast: Implications for HIV-1 Vaccine Development.” Journal of Clinical Immunology. Online First. 2006 May.
- Singh, N, Aguado, J, Bonatti, H, Forrest, G, Barron, M, Madinger, N, Fortun, J, and the Zygomycetes Treatment Study Group. “Risk Factors for Zygomycosis in Solid Organ Transplant (SOT) Recipients: A Prospective, Case controlled, Multicenter, International Study.” Abstract/Poster presentation at the 47th Ann. Mtg. of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago. 2007.
- Ostrosky-Zeichner, L, Sobel, J, Pappas, P, Shoham, S, Barron, M, Reboli, A, Kauffman, C, Donowitz, G, Clark, N, Walsh, T, Akins, R, Madviwala, T, Shinde, R, Bradley, ME, Nolen, T, Kendrick, A, Wallace, D. “Pilot Study of Risk-Based Caspofungin (CFG) Prophylaxis in the ICU: Lessons from a Multicenter, Randomized, Double Blind Trial and Insights Into Diagnostic Performance of Surrogate Markers.” Abstract/Poster presentation at the 47th Ann. Mtg. of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago. 2007.
- Gwanzura, L, Samneka, L, Samaneka W, Mugutso, A, Mudzviti, E, Mutimuri, E, Mutimuir, M, Taziwa, A, Ndemera, B, Tinago, W, Mandozana, G, Hakim, J, Borok, M, Campbell, T, Barron, M, Connick, E. “Identification and Presentation of Primary HIV-1-infection in Harare, Zimbabwe.” Abstract/poster presentation at the XVII International AIDS Conference, Mexico City, D.F. 2008.
- Singh, N, Aguado, J, Forrest, G, Barron, M, Bonatti, H, and the Zygomycetes Treatment Study Group. “Unique Propensity of Liver Transplant Recipients to Disseminated Disease and Earlier Onset of Post-transplant Zygomycosis: Results from a Prospective, Multicenter Study.” Abstract/Poster presentation at the 48th Ann. Mtg. of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th Annual Meeting, Washington, D.C. 2008.
- Jenkins, T, McCollister, B, Sharma, R, Barron, M, Bessesen, M, Madinger, N, Price, C, and Burman, W. “Epidemiology of Health Care-Associated MRSA USA300 Bloodstream Infections.” Abstract/Poster presentation at the 48th Ann. Mtg. of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th Annual Meeting, Washington, D.C. 2008.
- Kapoor, M, Hulett, T, Schraeder, N, and Barron, MA. “Catheter Related Bloodstream Infection Prevention in the Adult ICUs.” Oral Abstract presentation at the 20th Annual Rocky Mountain Regional Multidisciplinary Research & Evidence-Based Practice Symposium, Improving Patient Outcomes through Evidence-Based Practices. Denver, CO. 2009.
- Singh, N, Aguado, J, Bonatti, H, Forrest, G, Barron, M and the Zygomycosis Transplant Study Group. “Pulmonary zygomycosis in solid organ transplant recipients: risks and outcomes in the current era.” Oral Abstract presentation at American Transplant Congress 09. Boston, MA. 2009.
- Barron, MA, Gao, D, Springer, K, Patterson, JA, Brunvald, MW, McSweeney, PA, Zeng, C, Baron, AE, and Weinberg, A. “Cytomegalovirus (CMV) Immune Responses of Hematopoietic Stem Cell Transplant (HSCT) Recipients Do Not Predict Cytomegalovirus Viremia or Disease.” Abstract/Poster presentation at the 2009 Cytomegalovirus Workshop. Boston, MA. 2009.
- Barron, MA and Madinger, NM. “Prevention and Management of Opportunistic Fungal Infections in the Immunosuppressed Host, Part 1: Review of Antifungal Treatments and Prophylaxis. Infections in Medicine. Infections in Medicine. 25(10):448-456, 2008 October.
- Barron, MA and Madinger, NM. “Prevention and Management of Opportunistic Fungal Infections in the Immunosuppressed Host, Part 2: Candida and Aspergillus. Infections in Medicine. 25(11):498-505, 2008 November.
- Barron, MA and Madinger, NM. “Prevention and Management of Opportunistic Fungal Infections in the Immunosuppressed Host, Part 3: Cryptococcosis, Histoplasmosis, Coccidiodomycosis, and Emerging Molds. Infections in Medicine. 25(12):539-548, 2008 December.
- Barron, MA, Woods, PA, Campbell, G, Madinger, NE. “Septic Platelet Transfusion Reactions Due to Staphylococcus aureus.” Infection Control and Hospital Epidemiology. 30(1):101-102. 2009 January.
- Jenkins, TC, McCollister, BD, Sharma, R, McFann, KK, Madinger, NE, Barron, MA, Bessessen, M, Price, CS, Burman, WJ. “Health care-associated bloodstream infections caused by the methicillin-resistant Staphylococcus aureus USA3003 strain in three affiliated hospitals.” Infection Control and Hospital Epidemiology, Infection Control and Hospital Epidemiology. 30(3):233-241. 2009 March.
- Gwanzura, L, Samaneka, L, Samaneka, W, Mudzviti, E, Mutimuri, M, Taziwa, A, Ndemera, B, Tinago, W, Mandozana, G, Hakim, J, Borok, M, Campbell, T, Barron, M, and Connick, E. “Identification and presentation of primary HIV-1 infection in Harare, Zimbabwe.” Abstract/Poster Presentation at the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Cape Town, South Africa. 2009.
- Fish, D, Hilts, A, Urban, J, and Barron, M. “Sustained Effectiveness of a Three Year Fluoroquinolone Restriction Policy at a University Teaching Hospital.” Oral abstract presentation at the 49th Ann. Mtg. of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Francisco, CA. 2009.
- Barron, MA, Gao, D, Springer, KL, Patterson, JA, Brunvand, MW, McSweeney, PA, Zeng, C, Barón, AE, Weinberg, A. “Relationship of reconstituted adaptive and innate CMV-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.” Clin Infect Dis 49:1777-83. 2009 Dec.
- Sun, H-Y, Aguado, JM, Bonatti, H, Forrest, G, Gupta, KL, Sadafar, N, John, GT, Pursell, J, Muñoz, P, Patel, R, Fortun, J, Martin-Davila, P, Philippe, B, Philit, F, Tabah, A, Terzi, N, Chatelet, V, Kusne, S, Clark, N, Blumberg, E, Julia, MB, Humar, A, Houston, S, Lass-Flörl, C, Johnson, L, Dubberke, ER, Barron, MA, Lortholary, O, Singh, N, and the Zygomycosis Transplant Study Group. “Pulmonary Zygomycosis in Solid Organ Transplant Recipients: Risks and Outcomes in the Current Era.” American Journal of Transplantation 9:1-6. 2009 July.
- Singh, N, Aguado, JM, Bonatti, H, Forrest, G, Gupta, KL, Safdar, N, John, GT, Pursell, KJ, Muñoz, P, Patel, R, Fortun, J, Martin-Davila, P, Philippe, B, Philit, F, Tabah, A, Terzi, N, Chatelet, V, Kusne, S, Clark, N, Blumberg, E, Julia, MB, Humar, A, Houston, S, Lass-Flörl, C, Johnson, L, Dubberke, ER, Barron, MA, and Lortholary, O. “Zygomycosis in Solid Organ Transplant Recipients: A Prospective, Matched Case-Control Study to Assess Risks for Disease and Outcome.” J Infect Dis 200 (6): 1002-1011. 2009 Sept.
- Ostrosky-Zeichner, L, Pappas, PG, Shoham, S, Reboli, A, Barron, MA, Sims, C, Wood, C, Sobel, J. “Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the ICU.” Mycoses 2009. In press.
- Go, AC, Golightly, LK, Barber, GR, and Barron, MA. “Linezolid Interaction with Serotonin Reuptake Inhibitors: Report of Two Cases and Incidence Assessment.” Drug Metabolism and Drug Interactions 2010. 25(1-4):41-7.
- Barron, MA, Borok, M, Allshouse, A, Hakin, J, Campbell, T, Thompson, M, Gwanzura, L, MaWhinney, S, Dehlinger, M, Connick, E, and the COZI study group.“A Randomized, Controlled Trial of 12 Weeks Antiretroviral Therapy Versus CD4 T Cell Guided Therapy in Subjects with Acute or Recent HIV-1 Infection in the US and Africa.” Abstract/Poster Presentation at the XVIII International AIDS Conference, Vienna, Austria. 2010
- Ostrosky-Zeichner, L, Shoham, S, Vazquez, J, Reboli, A, Betts, A, Barron, M, Schuster, M, Judson, M, Revankar, S, Caeiro, JP, Mangino, JE, Mushatt, D, Bedimo, R, Freifield, A, Nguyen, MH, Kauffman, C, Larsen, RA, Dismukes, WE, Westfall, AO, Deerman, JB, Woods, C, Sobel, JD, and Pappas, PG. “MSG-01: A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of Caspofungin Prophylaxis vs Placebo Followed by Pre-Emptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting – Preliminary Results.” Oral Abstract Presentation at the 21st Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, Dallas, TX. 2011.
- Barron, MA, Richardson, K, Hilts, AE, and Levi, M. “A retrospective trial to evaluate the safety and efficacy of anidulafungin in individuals with hepatic dysfunction including liver transplant recipients.” Abstract/Poster Presentation at the 21st European Congress of Clinical Microbiology and Infectious Diseases/27th International Congress of Chemotherapy, Milan, Italy. 2011.
- 1. Barron, MA. “Medical Mycology for the Hospital Epidemiologist.” Current Fungal Infection Reports. 6(1):74-80, 2012 February.
- Centers for Disease Control and Prevention (CDC). Reported by Pisney L, Barron M, Jackson S, Bamberg W, MacConnell D, Kallen A, Gould C, Limbago B, Epson E (corresponding contributor), Wendt J. “Notes from the Field: Hospital Outrbeak of Carbapenem-Resistant Klebsiella pneumonia Producing New Delhi Metallo Beta-Lactamase - Denver, Colorado, 2012.” Morbidity and Mortality Weekly Report. 2013 Feb 15;62:108.
- Golightly, LK, Barber, GR, Barron, MA, and Page III, RL. “Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability.” Drug Metabolism and Drug Interactions. 28(1): 1-10. 2012.
- Epson EE, Wendt J, Pisney L, MacCannell D, S. Jackson Janelle, S, Kitchel B, O’Connell H, Rasheed JK, Limbago B, Gould C, Kallen A, Barron M, Bamberg W. “Carbapenem-Resistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase at an Acute-Care Hospital - Denver, Colorado, 2012.” Oral abstract presentation at EIS Conference. Atlanta, GA. 2013.
- Flynn Makic, MB, Burton, L, Hulett, T, Schomer, K, Barron, M. “Basinless Baths and Chlorhexidine Bathing to Reduce Hospital Acquired Infections” Abstract/Poster presentation at the National Teaching Institute and Critical Care Exposition, AACN, Boston, MA. 2013.
- Flynn Makic, MB, Burton, L, Hulett, T, Schomer, K, Barron, M. “Basinless Baths and Chlorhexidine Bathing to Reduce Hospital Acquired Infections” Oral abstract presentation at the 24th Annual Rocky Mountain Interdisciplinary Research & Evidence-Based Practice Symposium, Denver, CO. 2013.
- Singh, N, Wagener, M, Suarez JF, Lass-Floerl, C, Avery, R, Pasqualotto, A, Lyon, GM, Barron, M, Montoya J. “Invasive Aspergillosis (IA)-Associated Immune Reconstitution Syndrome (IRS) in Lung Transplant Recipients.” Oral abstract presentation at the 52nd Ann. Mtg. of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Francisco, CA. 2012.
- Singh, N, Wagener, M, Suarez JF, Lass-Floerl, C, Avery, R, Pasqualotto, A, Lyon, GM, Barron, M, Montoya, J. “Airway Invasive Pulmonary Aspergillosis (Airway IPA) versus AngioInvasive Pulmonary Aspergillosis (Angio IPA) Have Distinct Risk Factors and Outcomes in Lung Transplant Recipients.” Abstract/Poster Presentation at the 52nd Ann. Mtg. of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Francisco, CA. 2012.
- Flynn Makic, MB, Burton, L, Hulett, T, Schomer, K, and Barron, MA. “Basinless Baths to Reduce Hospital Acquired Infections.” Abstract/Poster Presentation at ANCC National Magnet Conference, Los Angeles, CA. 2012.
- Singh N, Suarez JF, Avery R, Lass-Flörl C, Geltner C, Pasqualotto AC, Lyon GM, Barron M, Husain S, Wagener MM, Montoya JG. Immune reconstitution syndrome-like entity in lung transplant recipients with invasive aspergillosis. Transpl Immunol. 2013 Dec;29(1-4):109-13. PubMed PMID: 24076039
- Henao-Martínez AF, Castillo-Mancilla JR, Barron MA, Nichol AC. Combination Antifungal Therapy in the Treatment of Scedosporium apiospermum Central Nervous System Infections. Case Rep Infect Dis. 2013;2013:589490. PubMed PMID: 23738164
- Singh N, Suarez JF, Avery R, Lass-Flörl C, Geltner C, Pasqualotto AC, Marshall Lyon G, Barron M, Husain S, Wagener MM, Montoya JG. Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis. J Infect. 2013 Jul;67(1):72-8. PubMed PMID: 23567625
- Golightly LK, Barber GR, Barron MA, Page RL 2nd. Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability. Drug Metabol Drug Interact. 2013;28(1):49-58. PubMed PMID: 23314530
- Faubel S, Franch H, Vijayan A, Barron MA, Heung M, Liu KD, Koyner JL, Conner MJ Jr. Preparing for renal replacement therapy in patients with the ebola virus disease. Blood Purif. 2014;38(3-4):276-85. PubMed PMID: 25675963
- Pisney LM, Barron MA, Kassner E, Havens D, Madinger NE. Carbapenem-resistant Enterobacteriaceae rectal screening during an outbreak of New Delhi metallo-ß-lactamase-producing Klebsiella pneumoniae at an acute care hospital. Infect Control Hosp Epidemiol. 2014 Apr;35(4):434-6. PubMed PMID: 24602952
- Epson EE, Pisney LM, Wendt JM, MacCannell DR, Janelle SJ, Kitchel B, Rasheed JK, Limbago BM, Gould CV, Kallen AJ, Barron MA, Bamberg WM. Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-ß-lactamase at an acute care hospital, Colorado, 2012. Infect Control Hosp Epidemiol. 2014 Apr;35(4):390-7. PubMed PMID: 24602944
- Ostrosky-Zeichner L, Shoham S, Vazquez J, Reboli A, Betts R, Barron MA, Schuster M, Judson MA, Revankar SG, Caeiro JP, Mangino JE, Mushatt D, Bedimo R, Freifeld A, Nguyen MH, Kauffman CA, Dismukes WE, Westfall AO, Deerman JB, Wood C, Sobel JD, Pappas PG. MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis. 2014 May;58(9):1219-26. PubMed PMID: 24550378
- Janelle, SJ, Kovar, V, Barron, MA, Campbell, TB; Smith, RM, Park, BJ, Bamberg, WM. “Increase in Mucormycosis Following a Hundred Year Flood in Colorado.” Abstract/Poster presentation 2014 Annual Conference of the Council of State and Territorial Epidemiologists. Nashville, TN. 2014.
- Barron, MA, Richardson, K, McCollister, B. “Risk factors and influence of carbapenem exposure on the development of carbapenem resistant Pseudomonas aeruginosa bloodstream infections.” Abstract/Poster presentation at 24th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, Spain. 2014.
- Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ. Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients. Infect Control Hosp Epidemiol. 2015 Nov;36(11):1251-60. PubMed PMID: 26224364
- Gerding DN, Meyer T, Lee C, Cohen SH, Murthy UK, Poirier A, Van Schooneveld TC, Pardi DS, Ramos A, Barron MA, Chen H, Villano S. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA. 2015 May 5;313(17):1719-27. PubMed PMID: 25942722
- Barron MA, Leung DY. Lessons from Ebola and readiness for new emerging infectious threats. J Allergy Clin Immunol. 2015 Apr;135(4):872-4. PubMed PMID: 25843599
- Faubel S, Franch H, Vijayan A, Barron MA, Heung M, Liu KD, Koyner JL, Conner MJ Jr. Preparing for renal replacement therapy in patients with the Ebola virus disease. Blood Purif. 2014;38(3-4):276-85. PubMed PMID: 25675963
- Barron MA, Richardson K, Jeffres M, McCollister B. Risk factors and influence of carbapenem exposure on the development of carbapenem resistant Pseudomonas aeruginosa bloodstream infections and infections at sterile sites. Springerplus. 2016 Jun 17;5(1):755. PubMed PMID: 27386239
- Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J 4th, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ. Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14. J Clin Virol. 2016 Jul;80:12-9. PubMed PMID: 27130980
- Barron MA, Frank DN, Claypool D, Ir D, Ning MF, Curtis D, Weinberg A. Antibody responses to influenza a H1N1 vaccine compared to the circulating strain in influenza vaccine recipients during the 2013/2014 season in North America. J Clin Virol. 2016 Oct;83:56-60. PubMed PMID: 27591557
- Miller MA, Fish DN, Barber GR, Barron MA, Goolsby TA, Moine P, Mueller SW. A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections. J Microbiol Immunol Infect. 2018 Aug 18. [Epub ahead of print] PubMed PMID: 30190234
- Lodise TP, Rosenkranz SL, Finnemeyer M, Evans S, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, Wunderink RG, Rodriguez M, Schrank J, Bleasdale SC, Schultz S, Barron M, Stapleton A, Wray D, Chambers H, Fowler V, Holland TL. The Emperor's New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE). Clin Infect Dis. 2019 Jun 3. [Epub ahead of print] PubMed PMID: 31157370
- Goss FR, Bookman K, Barron M, Bickley D, Landgren B, Kroehl M, Williamson K, Zane R, Wiler J. Improved antibiotic prescribing using indication-based clinical decision support in the emergency department. J Am Coll Emerg Physicians Open. 2020 Jun;1(3):214-221. PubMed PMID: 33000036
- King M, Hurley H, Davidson KR, Dempsey EC, Barron MA, Chan ED, Frey A. The Link between Fusobacteria and Colon Cancer: a Fulminant Example and Review of the Evidence. Immune Netw. 2020 Aug;20(4):e30. PubMed PMID: 32895617
- Mann S, Tobolowsky F, Purohit S, Henao-Martínez A, Bajrovic V, Ramanan P, Wolfel E, Khazanie P, Barron M, Madinger N, Benamu E. Cryptococcal pericarditis in a heart transplant recipient. Transpl Infect Dis. 2020 Dec;22(6):e13366. PubMed PMID: 32533755
- Lodise TP, Rosenkranz SL, Finnemeyer M, Evans S, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, Wunderink RG, Rodriguez M, Schrank J, Bleasdale SC, Schultz S, Barron M, Stapleton A, Wray D, Chambers H, Fowler VG, Holland TL. The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE). Clin Infect Dis. 2020 Apr 10;70(8):1536-1545. PubMed PMID: 31157370
- Miller MA, Fish DN, Barber GR, Barron MA, Goolsby TA, Moine P, Mueller SW. A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections. J Microbiol Immunol Infect. 2020 Apr;53(2):321-327. PubMed PMID: 30190234
- Embi PJ, Levy ME, Naleway AL, Patel P, Gaglani M, Natarajan K, Dascomb K, Ong TC, Klein NP, Liao IC, Grannis SJ, Han J, Stenehjem E, Dunne MM, Lewis N, Irving SA, Rao S, McEvoy C, Bozio CH, Murthy K, Dixon BE, Grisel N, Yang DH, Goddard K, Kharbanda AB, Reynolds S, Raiyani C, Fadel WF, Arndorfer J, Rowley EA, Fireman B, Ferdinands J, Valvi NR, Ball SW, Zerbo O, Griggs EP, Mitchell PK, Porter RM, Kiduko SA, Blanton L, Zhuang Y, Steffens A, Reese SE, Olson N, Williams J, Dickerson M, McMorrow M, Schrag SJ, Verani JR, Fry AM, Azziz-Baumgartner E, Barron MA, Thompson MG, DeSilva MB. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 5;70(44):1553-1559. PubMed PMID: 34735426
- Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, DeSilva MB, Natarajan K, Bozio CH, Lewis N, Dascomb K, Dixon BE, Birch RJ, Irving SA, Rao S, Kharbanda E, Han J, Reynolds S, Goddard K, Grisel N, Fadel WF, Levy ME, Ferdinands J, Fireman B, Arndorfer J, Valvi NR, Rowley EA, Patel P, Zerbo O, Griggs EP, Porter RM, Demarco M, Blanton L, Steffens A, Zhuang Y, Olson N, Barron M, Shifflett P, Schrag SJ, Verani JR, Fry A, Gaglani M, Azziz-Baumgartner E, Klein NP. Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings. N Engl J Med. 2021 Oct 7;385(15):1355-1371. PubMed PMID: 34496194
- Bozio CH, Grannis SJ, Naleway AL, Ong TC, Butterfield KA, DeSilva MB, Natarajan K, Yang DH, Rao S, Klein NP, Irving SA, Dixon BE, Dascomb K, Liao IC, Reynolds S, McEvoy C, Han J, Reese SE, Lewis N, Fadel WF, Grisel N, Murthy K, Ferdinands J, Kharbanda AB, Mitchell PK, Goddard K, Embi PJ, Arndorfer J, Raiyani C, Patel P, Rowley EA, Fireman B, Valvi NR, Griggs EP, Levy ME, Zerbo O, Porter RM, Birch RJ, Blanton L, Ball SW, Steffens A, Olson N, Williams J, Dickerson M, McMorrow M, Schrag SJ, Verani JR, Fry AM, Azziz-Baumgartner E, Barron M, Gaglani M, Thompson MG, Stenehjem E. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 5;70(44):1539-1544. PubMed PMID: 34735425
Practice Locations
UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus1635 Aurora Ct
Aurora, CO 80045
720-848-0000
UCHealth Infectious Disease Clinic - Anschutz Medical Campus
1635 Aurora Ct
7th Floor
Aurora, CO 80045
720-848-0191
Hospital Affiliation
- University of Colorado Hospital
Specialty Information
Specialties- Infectious Disease, Board Certification (2010)
- Internal Medicine, Board Certification (2011)
Care Philosophy
Dr. Michelle Barron is the senior medical director of infection prevention and control for UCHealth, a nationally recognized health care system with operating revenue of $5.0 billion, a workforce of more than 25,000 people and 12 hospitals, including the state’s only academic medical center. As one of the top infectious disease experts in Colorado, she brings her expertise to the entire UCHealth system, working from UCHealth University of Colorado Hospital on the Anschutz Medical Campus. After graduating from Yale in 1992, she returned to her home state of Texas for medical school at the University of Texas Southwestern Medical Center in Dallas. While there, Dr. Barron found her calling in infectious disease while treating people affected by AIDS. She then completed her internship and residency program at Creighton University before coming to Colorado in 1999 to begin her fellowship at the University of Colorado. For much of her career at University of Colorado Hospital, Dr. Barron has served as medical director of infection prevention and control. She is board certified in infectious disease and internal medicine. She’s also a professor at the University of Colorado School of Medicine. Dr. Barron has led the charge against infectious diseases including the H1N1 flu pandemic in 2009 and Ebola in 2015. Since January 2020 and the beginning of the COVID-19 pandemic, she has worked around the clock with fellow leaders to protect patients, staff and providers across UCHealth. Her message has always been comforting and clear; “This is what we do. We take care of sick patients. We know how to do this.” While coping with the pandemic, Dr. Barron has kept twin missions top of mind; providing extraordinary care to patients while protecting caregivers. Dr. Barron is also a member of the Colorado Governor’s Expert Emergency Epidemic Response Committee (GEEERC). When Dr. Barron isn’t tackling infectious diseases and pandemics, you can find her traveling the globe with her husband Greg, playing with her dog Chase and inspiring others with her trademark positivity and strength.
Dr. Michelle Barron is the senior medical director of infection prevention and control for UCHealth, a nationally recognized health care system with operating revenue of $5.0 billion, a workforce of more than 25,000 people and 12 hospitals, including the state’s only academic medical center. As one of the top infectious disease experts in Colorado, she brings her expertise to the entire UCHealth system, working from UCHealth University of Colorado Hospital on the Anschutz Medical Campus. After graduating from Yale in 1992, she returned to her home state of Texas for medical school at the University of Texas Southwestern Medical Center in Dallas. While there, Dr. Barron found her calling in infectious disease while treating people affected by AIDS. She then completed her internship and residency program at Creighton University before coming to Colorado in 1999 to begin her fellowship at the University of Colorado. For much of her career at University of Colorado Hospital, Dr. Barron has served as medical director of infection prevention and control. She is board certified in infectious disease and internal medicine. She’s also a professor at the University of Colorado School of Medicine. Dr. Barron has led the charge against infectious diseases including the H1N1 flu pandemic in 2009 and Ebola in 2015. Since January 2020 and the beginning of the COVID-19 pandemic, she has worked around the clock with fellow leaders to protect patients, staff and providers across UCHealth. Her message has always been comforting and clear; “This is what we do. We take care of sick patients. We know how to do this.” While coping with the pandemic, Dr. Barron has kept twin missions top of mind; providing extraordinary care to patients while protecting caregivers. Dr. Barron is also a member of the Colorado Governor’s Expert Emergency Epidemic Response Committee (GEEERC). When Dr. Barron isn’t tackling infectious diseases and pandemics, you can find her traveling the globe with her husband Greg, playing with her dog Chase and inspiring others with her trademark positivity and strength.